Home › Funds › CADIAN CAPITAL MANAGEMENT, LP › EVH
CADIAN CAPITAL MANAGEMENT, LP position in EVH
EVOLENT HEALTH INC · Consumer Discretionary
CADIAN CAPITAL MANAGEMENT, LP reported holding 509,464 shares of EVH (EVOLENT HEALTH INC) in its Q3 2026 13F filing — a position valued at US$1.8M, representing 0.15% of its reported portfolio and ranking #26 among its reported holdings. CADIAN CAPITAL MANAGEMENT, LP has disclosed EVH holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How CADIAN CAPITAL MANAGEMENT, LP's EVH position evolved
CADIAN CAPITAL MANAGEMENT, LP first disclosed a stake in EVH in Q4 2024 at 5,225,001 shares (US$58.8M). The position peaked in Q2 2025 at 10,424,701 shares, worth US$117.4M. Across 8 filings, CADIAN CAPITAL MANAGEMENT, LP increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 509,464 shares valued at US$1.8M — a reduction of -10,305,009 shares quarter over quarter.. Notable position changes include a 107% increase in Q1 2025 (shares rose 19% over the following quarter), a 95% trim in Q3 2026 (shares rose 40% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 5.23M | $58.78M | New |
| Q1 2025 | 10.79M | $102.22M | Add |
| Q2 2025 | 10.42M | $117.38M | Reduce |
| Q3 2025 | 11.73M | $99.23M | Add |
| Q4 2025 | 11.09M | $44.34M | Reduce |
| Q1 2026 | 10.81M | $24.66M | Reduce |
| Q2 2026 | 10.81M | $58.61M | Hold |
| Q3 2026 | 509.46K | $1.78M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EVH and 13F data
EVH (EVOLENT HEALTH INC) is a Consumer Discretionary company. 7 other funds we track also report a position in EVH — the largest reported positions include DeepCurrents Investment Group LLC (US$21.7M), Rubicon Founders LLC (US$19.7M), PenderFund Capital Management Ltd. (US$19.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EVH
- DeepCurrents Investment Group LLC 29.99M sh · $21.70M · Q3 2026
- Rubicon Founders LLC 5.64M sh · $19.69M · Q3 2026
- PenderFund Capital Management Ltd. 23.37M sh · $19.02M · Q2 2026
More on CADIAN CAPITAL MANAGEMENT, LP
FAQ
How long has CADIAN CAPITAL MANAGEMENT, LP held EVH?
CADIAN CAPITAL MANAGEMENT, LP has disclosed EVH holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is CADIAN CAPITAL MANAGEMENT, LP's current position in EVH?
As of Q3 2026, CADIAN CAPITAL MANAGEMENT, LP holds 509.46K shares of EVH (EVOLENT HEALTH INC), valued at $1.78M, representing 0.15% of its reported portfolio and ranking #26.
Has CADIAN CAPITAL MANAGEMENT, LP been buying or selling EVH?
In the latest 13F filing (Q3 2026), CADIAN CAPITAL MANAGEMENT, LP reduced its position in EVH. The position peaked in Q2 2025 at 10.42M shares.
Which other funds hold EVH?
Other major institutional holders of EVH include DeepCurrents Investment Group LLC, Rubicon Founders LLC, PenderFund Capital Management Ltd., among 7 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.